(Q77977978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Eradication of a disease: how we cured symptomless prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

eradication of infectious diseases

9 December 2019

main subject

1 reference

1

Ian F Tannock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

9314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

1341-1342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

Geographic pathology of latent prostatic carcinoma

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Rate of relapse following treatment for localized prostate cancer: a critical analysis of retrospective reports

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Immunoperoxidase localization of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

PSAdynia and other PSA-related syndromes: a new epidemic--a case history and taxonomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Prostate cancer incidence and mortality in the United States and the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Asymptomatic incidence and duration of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908278-8

7 January 2021

10.1016/S0140-6736(02)08278-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11965297%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference